Dexmedetomidine as adjunct in awake craniotomy – improvement or not?

BACKGROUND: Over the last decade, awake craniotomy for tumor resection has become a standard to maximize tumor resection and minimize the risk of permanent neurological deficits. Different techniques and medication regimes have been tested for this procedure. Until today there is no consensus on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Raimann, Florian J., Adam, Elisabeth H., Strouhal, Ulrich, Zacharowski, Kai, Seifert, Volker, Forster, Marie-Therese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original and Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173139/
https://www.ncbi.nlm.nih.gov/pubmed/32090308
http://dx.doi.org/10.5114/ait.2020.93043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173139/
https://www.ncbi.nlm.nih.gov/pubmed/32090308
http://dx.doi.org/10.5114/ait.2020.93043

Ejemplares similares